Literature DB >> 8590492

Neuroleptic malignant-like syndrome: a complication of acute organophosphate poisoning.

G Ochi1, K Watanabe, H Tokuoka, S Hatakenaka, T Arai.   

Abstract

We report a 60-yr-old woman with schizophrenia, who manifested a neuroleptic malignant (NM)-like syndrome after acute organophosphate poisoning (OPP). She attempted suicide by ingesting 40% emulsions of DMTP (S-2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadizol-3-yl-methyl O,O-dimethyl phosphorodithioate) 100 ml. On admission, she was unconscious and demonstrated convulsions, depressed respiratory movements, miosis and profuse salivation. Plasma cholinesterase concentration (842 IU.L-1) was very low and OPP was diagnosed. She was treated with gastric lavage, atropine and pralidoxime (PAM). By the seventh day after admission, symptoms of OPP disappeared and serum ChE had recovered to a sub-normal level. On the 13th day, she demonstrated coma, high fever (41.0 degrees C) and lead-pipe rigidity. Serum CPK was increased (1631 IU.L-1). Dantrolene sodium iv was administered for three days. Body temperature began to decrease in 24 hr, and her consciousness, muscle rigidity and other neurological symptoms returned to normal by the 16th day after admission. She was discharged from the hospital without sequelae 55 days after admission. We conclude that OPP can predispose to an NM-like syndrome and that dantrolene may be effective in the management.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590492     DOI: 10.1007/bf03011077

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  11 in total

1.  Dantrolene in lethal catatonia.

Authors:  A Pennati; E Sacchetti; A Calzeroni
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

Review 2.  Organophosphorus insecticide poisoning.

Authors:  L Karalliedde; N Senanayake
Journal:  Br J Anaesth       Date:  1989-12       Impact factor: 9.166

3.  Difficulty in weaning from respiratory support in a patient with the intermediate syndrome of organophosphate poisoning.

Authors:  R J Routier; J Lipman; K Brown
Journal:  Crit Care Med       Date:  1989-10       Impact factor: 7.598

Review 4.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

5.  Historical perspective of organophosphorus ester-induced delayed neurotoxicity.

Authors:  R L Metcalf
Journal:  Neurotoxicology       Date:  1982-12       Impact factor: 4.294

6.  Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome.

Authors:  N Senanayake; L Karalliedde
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

7.  A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.

Authors:  J H Friedman; S S Feinberg; R G Feldman
Journal:  JAMA       Date:  1985-11-15       Impact factor: 56.272

8.  Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.

Authors:  R E Burke; S Fahn; R Mayeux; H Weinberg; K Louis; J H Willner
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

Review 9.  Neuroleptic malignant syndrome.

Authors:  R J Abbott; L A Loizou
Journal:  Br J Psychiatry       Date:  1986-01       Impact factor: 9.319

Review 10.  Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome.

Authors:  E Castillo; R T Rubin; E Holsboer-Trachsler
Journal:  Am J Psychiatry       Date:  1989-03       Impact factor: 18.112

View more
  6 in total

1.  Neuroleptic Malignant Syndrome.

Authors:  N Ravishankar
Journal:  Indian J Pediatr       Date:  2015-10-08       Impact factor: 1.967

2.  Recurrent spontaneous "neuroleptic malignant syndrome" in the absence of neuroleptic medication in probable dementia with Lewy bodies.

Authors:  K E Weber; R A Linker; R Lorenz; W Muellges; M Naumann; K Reiners; J Classen
Journal:  J Neurol       Date:  2005-03-14       Impact factor: 4.849

3.  Regulation of body temperature after acute organophosphate poisoning.

Authors:  P Hantson; P Hainaut; M Vander Stappen; P Mahieu
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

4.  Hypothermia and Fever after organophosphorus poisoning in humans--a prospective case series.

Authors:  Alison Moffatt; Fahim Mohammed; Michael Eddleston; Shifa Azher; Peter Eyer; Nick A Buckley
Journal:  J Med Toxicol       Date:  2010-12

5.  Neuroleptic malignant syndrome associated with acute organophosphate poisoning: Case report

Authors:  Nancy Y Angulo; Paula A Castaño; Crhistian C Gómez; Santiago Quintero
Journal:  Biomedica       Date:  2022-09-02       Impact factor: 1.173

6.  Temperature changes among organophosphate poisoned patients, Tehran- Iran.

Authors:  Haleh Talaie; Hamid Owliaey; Abdolkarim Pajoumand; Mona Gholaminejad; Omid Mehrpour
Journal:  Daru       Date:  2012-10-15       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.